← Leaderboards
Alfredo Garzino-Demo
University Of Md Biotechnology Institute
$2,350,471
Attributed
$2,545,633
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $388.3K · FY2009–18$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,545,633 · 3
By mechanism
R01$2,100,133 · 2
R21$445,500 · 1
Top collaborators
- Sean Ekins2 shared
Most similar at University Of Md Biotechnology Institute
Same institution · by research overlap
- James T. Stivers$16,239,758
- William Conrad Reid$1,544,214
- Michael K. Gilson$22,308,704
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsDefensinsInhibitor/AntagonistSymptomsAstrocytesInfectionMutantMacrophageCd4 Positive T LymphocytesVirusCellsNeuraxisPlayEnzyme-Linked Immunosorbent AssayAids Dementia ComplexEpithelial CellsAnti-Hiv AgentsDendritic CellsDominant-Negative MutationFlow CytometryChemokineBinding (Molecular Function)AbstractingCritical Pathways
Grant awards (10)
New generation of non-nucleoside RT HIV inhibitors avoiding HIV-associated neurocognitive disorders$196,300
R01 · FY2018 · NS
New generation of non-nucleoside RT HIV inhibitors avoiding HIV-associated neurocognitive disorders$194,024
R01 · FY2017 · NS
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection$319,175
R01 · FY2013 · NS · contact PI
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection$330,750
R01 · FY2012 · NS · contact PI
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection$378,512
R01 · FY2011 · NS · contact PI
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection$9,747
R01 · FY2011 · NS · contact PI
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection$334,125
R01 · FY2010 · NS · contact PI
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection$337,500
R01 · FY2009 · NS · contact PI
HIV suppression by Beta-defensins$222,750
R21 · FY2004 · DE
HIV suppression by Beta-defensins$222,750
R21 · FY2003 · DE